Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In June 2023, Lilly announced that Retatrutide achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight and a mean weight reduction up to 24.2% at 48 weeks during phase II studies
GLP-1
These results indicate that the ability of RHEA@Gel to absorb free radicals is not only significantly greater than that of natural VC but also greater than that of chemically synthesized AST
Plus, an array of weight loss options from compounded GLP-1 injections to custom oral medication kits reviewed and prescribed by a licensed healthcare provider and/or a custom blend of doctor-trusted ingredients, each shown to promote weight loss
Compounding allows precise dose customization
2025 Sept 7;15(17):2264
&srotate=0)
US$ 22.80
US$ 25.72
US$ 25.72
